<unk>  is not the first-line treatment option for patients with<unk><unk> . Renal transplantation is usually reserved for patients who present with undetectable circulating anti-glomerular basement antibodies in serum for 12 months and atleast 6 months after stopping the use of cytotoxic agents.
Goodpasture syndrome surgery
Membranous glomerulonephritis surgery
Churg-Strauss syndrome surgery
Microscopic polyangiitis surgery
Mixed connective tissue disease surgery
Renal artery stenosis surgery
IgA nephropathy surgery
Takayasu's arteritis surgery